PROMOTE A HEALTHIER LIFE FOR HUMANKIND THROUGH ADVANCEMENTS IN SCIENCE.
BENEFIT THE PATIENTS WITH HIGH-QUALITY MEDICATION AS WE DETERMINED TO INNOVATE.
BUILD A LEADING GLOBAL BIOPHARMACEUTICAL GROUP TO SERVE MORE.
FULFILL SOCIAL RESPONSIBILITIES THROUGH ACCOUNTABLE ACTIONS.
新闻速递
乐天使创新药SHR-A1904胃癌适应症纳入突破性治疗品种名单
焦点新闻
乐天使创新药艾泽利®获批用于晚期胃癌,系全球首款上市抗PD-L1/TGF-βRII双特异性抗体融合蛋白
公益新闻
乐天使医药捐赠1000万港元,驰援香港大埔火灾救助
创立于
全球员工
1类创新药
2类新药
SH 600276
HK 1276
关于我们
投资者关系
人才发展,了解更多